Open AccessThe ESCAPE randomized clinical trial: 20-80 mg of Zokor (Simvastatin) in patients with familial hypercholesterolemia in ischemia heart disease. Part 1. Hypolipidemic efficacy, safety and tolerance
Author(s) -
А. В. Сусеков,
М. Ю. Зубарева,
Т. А. Рожкова,
Н. Б. Горнякова,
Е. Ю. Соловьева,
Т. В. Балахонова,
Б. Д. Кулев,
O. Pogorelova,
A. Rogoza,
С. А. Бойцов,
В. В. Кухарчук
Publication year - 2009
Publication title -
arterialʹnaâ gipertenziâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.126
H-Index - 5
eISSN - 2411-8524
pISSN - 1607-419X
DOI - 10.18705/1607-419x-2009-15-5-543-549
Subject(s) - simvastatin , medicine , tolerability , adverse effect , randomized controlled trial , familial hypercholesterolemia , ischemia , cholesterol , cardiology , gastroenterology